Medical Device Registration Archives | GxP Cellators Consultants Ltd.

03/11/2025
IWFRxh3orDZddSrDsj76o.webp

Calibration of temperature-controlled trucks and trailers (used for GDP-compliant transportation of pharmaceutical, biopharmaceutical, and healthcare products) is a critical requirement under Good Distribution Practice (GDP) to ensure that the temperature monitoring and control systems accurately maintain and record product storage conditions during transit.

Here’s a comprehensive explanation of what calibration means in this context — including objectives, processes, regulatory expectations, documentation, and best practices.

Good Distribution Practice (GDP) Trainings | GxP Cellators

 

 1. Purpose of Calibration

Calibration of temperature-controlled trucks and trailers is a critical quality and compliance activity under Good Distribution Practice (GDP). It ensures that the temperature monitoring and control devices used during pharmaceutical transport are accurate, reliable, and traceable to recognized standards.

1.1 Why Calibration Is Necessary

Temperature-sensitive pharmaceutical and biopharmaceutical products — such as vaccines, biologics, insulin, blood products, and certain antibiotics — must be maintained within defined temperature ranges throughout storage and transportation.
Any deviation from these limits can impact product quality, potency, or stability, leading to:

  • Product degradation or loss of efficacy
  • Regulatory non-compliance
  • Product recalls or destruction
  • Potential patient safety risks

Calibration provides documented assurance that all temperature measuring, monitoring, and controlling devices installed in the vehicle are performing accurately and reflecting true temperature conditions.

1.2 Calibration Ensures Accurate Readings

Objective:
To confirm that all temperature sensors, controllers, and data loggers used in trucks/trailers are providing accurate and precise temperature measurements within defined tolerances.

Explanation:

Each sensor or probe inside the refrigerated compartment continuously monitors the internal air temperature. Over time, due to mechanical wear, environmental stress, or sensor drift, these instruments may lose accuracy.

Calibration verifies that the readings from these devices match the readings of a certified reference standard (traceable to NIST, NRC, or equivalent).

Example:

DeviceReference Temperature (°C)Sensor Reading (°C)Deviation (°C)Result
Sensor A (Front zone)5.05.3+0.3Pass
Sensor B (Rear zone)5.06.2+1.2Fail (out of tolerance)

Here, Sensor B deviates by +1.2°C, exceeding the allowable tolerance of ±0.5°C. This means the rear zone sensor must be recalibrated or replaced before use.

1.3 Ensures Consistent Temperature Maintenance

Objective:
To confirm that the temperature control system of the truck or trailer can consistently maintain the required temperature range throughout the transport cycle.

Explanation:

A calibrated system ensures that:

  • The set point on the controller accurately reflects the actual air temperature.
  • The refrigeration unit maintains uniform temperature distribution across all zones.
  • Temperature deviations trigger alarm systems at the correct thresholds.

Calibration therefore minimizes risk of temperature excursions (e.g., going above +8°C or below +2°C for refrigerated transport).

Example (Refrigerated Truck, 2–8°C):

During a temperature mapping study:

  • Front sensor: 4.8°C
  • Middle sensor: 5.2°C
  • Rear sensor: 7.6°C
    If calibration confirms all sensors are accurate within ±0.5°C, the system can be trusted to maintain stability.
    If one sensor shows drift, it may give false assurance — potentially masking a real excursion.

1.4 Ensures Data Integrity and Reliability

Objective:
To verify that the data loggers, monitoring systems, and recording devices generate accurate, reliable, and traceable data that can withstand regulatory scrutiny.

Explanation:

Regulators expect all temperature records (electronic or printed) used in product release and QA decisions to be accurate and trustworthy.
If a data logger or onboard recorder is not properly calibrated, even minor measurement errors could:

  • Misrepresent actual storage conditions
  • Lead to incorrect release decisions
  • Compromise data integrity under GDP or FDA Part 11 expectations

Example:

  • Data logger (Logger ID: LOG-001) shows: 8.1°C maximum during shipment
  • Reference standard calibration shows true temperature: 9.0°C
  • Result: Actual temperature exceeded 8°C limit → potential temperature excursion
    This example demonstrates how an uncalibrated logger can mask a real deviation, leading to non-compliance and potential product failure.

1.5 Ensures Compliance with Global GDP and Regulatory Requirements

Objective:
To ensure that the transportation process meets international GDP regulatory requirements that mandate regular calibration of all monitoring and control instruments.

Regulatory References:

Regulatory BodyRequirementReference
EU GDP (2013/C 343/01)Equipment used for monitoring and control must be calibrated at defined intervals.Chapter 3.2.3
WHO GDP (TRS 957, Annex 5)Monitoring devices should be calibrated at regular intervals against certified reference standards.Section 5.3.2
FDA 21 CFR 211.68Automatic equipment must be routinely calibrated and checked for accuracy.21 CFR 211.68(a)
Health Canada GUI-0069Temperature-controlled equipment must have documented calibration and maintenance.Section 4.1
MHRA GDP 2022Temperature monitoring systems must be maintained and calibrated to ensure reliability.Section 9.3
ANVISA RDC 430/2020Transport systems must ensure temperature monitoring and calibration traceability.Article 59

Example of Compliance:

A Canadian distributor using 10 refrigerated trucks ensures:

  • All sensors are calibrated annually using ISO 17025-accredited laboratory.
  • Calibration certificates are traceable to NIST/NRC standards.
  • QA reviews all calibration certificates before the vehicles are released for GDP operations.

During an MHRA GDP inspection, auditors may request:

  • Last calibration date and certificate for each truck
  • Proof of traceability to recognized standards
  • Calibration procedure and tolerance acceptance limits

Failure to provide evidence results in GDP deficiency observations (e.g., “Equipment not calibrated at defined intervals,” “Certificates not traceable to national standards”).

1.6 Summary of Purpose

In summary, calibration ensures that:

  1. Temperature readings are accurate → protecting product quality.
  2. Temperature control systems are reliable → preventing excursions.
  3. Recorded data are trustworthy → supporting release and audit decisions.
  4. GDP and global regulatory requirements are met → maintaining compliance and avoiding warnings.

Practical Industry Example

A pharmaceutical logistics company transports mRNA vaccines (storage requirement: –70°C ±10°C).

  • The truck’s digital display shows –72°C.
  • After calibration against a certified probe, true temperature found to be –60°C.
  • The discrepancy of 12°C indicates the display unit drifted significantly.
  • The company immediately stops shipments using this vehicle, recalibrates sensors, and requalifies the system.
  • QA documents deviation, investigates product impact, and implements tighter calibration frequency (every 6 months).

This action not only prevents regulatory non-compliance but also protects millions of dollars’ worth of sensitive vaccine product.

Good Distribution Practices (GDP) Certification

 

 

 2. Calibration Scope

Calibration of temperature-controlled trucks and trailers is not limited to a single instrument. It applies to all devices that monitor, control, or record environmental conditions, ensuring that pharmaceutical products remain within specified temperature and humidity ranges during transport. The following equipment is included in the calibration scope:

2.1. Temperature and Humidity Sensors / Probes

Purpose:
These sensors measure the actual conditions inside the cargo area. They are critical for ensuring the environment meets product-specific requirements.

Details:

  • Temperature probes: Measure air or product temperature inside refrigerated, frozen, or controlled room temperature compartments.
  • Humidity sensors: Monitor relative humidity for products sensitive to moisture (e.g., certain biologics, vaccines, or lyophilized products).
  • Examples:
    • PT100 or PT1000 temperature probes installed at the front, middle, and rear of the cargo area.
    • Capacitive humidity sensors maintaining 40–60% RH for hygroscopic materials.

Calibration Requirement:

  • Must be calibrated against traceable reference standards.
  • Check readings at multiple points across operational ranges (e.g., –20°C, 0°C, 5°C, 25°C for temperature; 30%, 50%, 70% for RH).

Example Table:

Sensor IDTypeLocationReference ReadingSensor ReadingDeviationStatus
T001TemperatureRear cargo5.0°C5.3°C+0.3°CPass
H001HumidityMiddle cargo50% RH51.2%+1.2%Pass

2.2.  Temperature Controllers and Display Units

Purpose:
Controllers regulate the HVAC/refrigeration unit to maintain the target temperature. Display units provide real-time readings for operators.

Details:

  • Controllers: PID controllers or integrated refrigeration system controllers that maintain setpoint temperature.
  • Displays: Digital or analog displays showing real-time compartment temperature.
  • Examples:
    • Controller setpoint: 5°C (2–8°C refrigerated transport)
    • Display shows 5.2°C → verify against calibrated reference probe.

Calibration Requirement:

  • Verify that the display reading matches reference standards.
  • Confirm that controller accurately triggers alarms when temperature deviates from the setpoint.

Example:

  • Set controller to 5°C, reference probe reads 5.0°C, display shows 5.3°C → Deviation +0.3°C → Pass.

2.3.  Recorders / Data Loggers Integrated with the Truck System

Purpose:
These devices provide continuous electronic records of environmental conditions during transport. Records are critical for regulatory audits, batch release decisions, and excursion investigations.

Details:

  • Types: Standalone loggers, integrated telematics, or cloud-based systems.
  • Function: Log temperature at defined intervals (e.g., every 1–5 minutes).
  • Examples: ELPRO, Sensitech, or TempTale loggers installed at multiple locations within the trailer.

Calibration Requirement:

  • Must record accurate values within defined tolerances.
  • Verify logger output against reference thermometer or simulator at multiple points.
  • Include as-found and as-left readings for audit documentation.

Example:

  • Logger shows 4.8°C at front zone, reference reads 5.0°C → deviation –0.2°C → Pass.
  • Logger records at 10-minute intervals → verified for timestamp accuracy and memory integrity.

2.4.  Wireless Monitoring Systems or Mapping Sensors Used During Transit

Purpose:
Wireless sensors and mapping devices track environmental conditions in real time and may transmit data to a central monitoring system.

Details:

  • Wireless sensors often include temperature, humidity, and GPS location tracking.
  • Mapping sensors simulate product locations to verify temperature uniformity across all zones.
  • Examples:
    • Bluetooth-enabled temperature probes for live tracking.
    • RFID-based or IoT-enabled environmental sensors for cold chain monitoring.

Calibration Requirement:

  • Each sensor must be verified against a reference standard.
  • Ensure signal integrity, timestamp synchronization, and data consistency with logger systems.

Example:

  • A wireless probe in the rear cargo zone reads 5.5°C while reference reads 5.0°C → deviation +0.5°C → Pass.
  • Check data transmission to the monitoring dashboard for accurate real-time recording.

2.5.  Any Alarm System Sensors

Purpose:
Alarms alert operators when temperature/humidity deviates outside predefined limits, preventing product compromise.

Details:

  • Alarm sensors may be integrated with controllers, displays, or data loggers.
  • Alarms include audible, visual, or remote notifications.
  • Examples:
    • Low-temperature alarm <2°C in refrigerated compartment.
    • High-temperature alarm >8°C for 2–8°C transport.

Calibration Requirement:

  • Verify that alarms activate at correct thresholds.
  • Test both local alarm function and remote notification (if applicable).

Example:

  • Simulate high temperature at 9°C → verify alarm activates and event is logged.
  • Simulate low temperature at 1.5°C → alarm triggers within 1 minute → Pass.

Summary

Calibration of temperature-controlled trucks and trailers applies to all instruments critical to maintaining environmental conditions, including:

Equipment TypePurposeCalibration Check
Temperature/Humidity SensorsMeasure cargo environmentCompare with reference standard at multiple points
Controllers / DisplaysMaintain and show setpointVerify reading and control accuracy
Data Loggers / RecordersRecord conditions over timeValidate readings, interval accuracy, memory integrity
Wireless / Mapping SensorsRemote real-time monitoringValidate reading, signal integrity, data logging
Alarm SensorsNotify deviationsTest threshold activation, functionality, and recording

By calibrating all these devices, the transport system ensures GDP-compliant, reliable, and auditable temperature control for sensitive pharmaceutical and biopharmaceutical products.

Good Distribution Practices (GDP)

 

3. Calibration Frequency

Proper calibration frequency is essential to ensure that all temperature and humidity monitoring, control, and recording devices continue to operate accurately throughout the vehicle’s service life. The frequency is determined based on regulatory requirements, risk assessment, manufacturer recommendations, and product sensitivity:

3.1.  Annual Calibration (Standard GDP Practice)

Purpose:

  • To maintain compliance with Good Distribution Practice (GDP) guidelines.
  • Ensures that all sensors, controllers, and data loggers maintain their accuracy over time.

Rationale:

  • Temperature sensors may drift gradually due to mechanical wear, vibration, environmental stress, or electronic aging.
  • Annual calibration provides documented assurance for regulators that all equipment is operating within defined tolerance.

Regulatory Reference:

  • EU GDP (2013/C 343/01): Equipment used for monitoring must be calibrated at defined intervals.
  • WHO GDP (TRS 957, Annex 5): Calibration should occur at regular intervals.

Example:

  • Truck TRK-001 has three sensors and one data logger. Last calibration was 10-Mar-2025.
  • Next calibration is scheduled 10-Mar-2026 (12-month interval).

3.2.  Before Initial Qualification of the Vehicle

Purpose:

  • To verify that the vehicle and all installed monitoring devices meet operational and regulatory requirements before first use for GDP transport.

Rationale:

  • Ensures that sensors, controllers, and loggers are accurate and functioning properly during initial qualification studies, such as:
    • Temperature mapping (Operational Qualification, OQ)
    • Performance Qualification (PQ) during simulated transport

Example:

  • A new refrigerated trailer is delivered to the warehouse.
  • Calibration is performed on all installed sensors and controllers before performing temperature mapping.
  • Reference thermometer readings match sensors within ±0.5°C → Vehicle qualifies for initial use.

3.3.  After Any Repair, Sensor Replacement, or System Modification

Purpose:

  • To ensure that the repair or modification does not impact measurement accuracy or system functionality.

Rationale:

  • Changes to the refrigeration unit, replacement of sensors, or software/firmware upgrades may affect the performance of temperature control and monitoring systems.
  • Regulatory agencies expect re-validation or calibration after such changes.

Examples:

  • Sensor Replacement: Rear cargo temperature sensor S3 replaced → calibration verifies new sensor matches reference readings.
  • Refrigeration Unit Repair: Compressor replaced → post-repair calibration ensures system maintains uniform temperature.
  • Controller Firmware Upgrade: Digital controller updated → calibration confirms setpoints and alarms function as expected.

Process:

  • Perform calibration as soon as the system is restored.
  • Record “as-found” and “as-left” readings for documentation and audit purposes.

3.4.  After Out-of-Tolerance (OOT) Calibration Results

Purpose:

  • To confirm that the system has been corrected and is now within acceptable tolerance.

Rationale:

  • When a sensor, controller, or data logger is found out-of-tolerance, it may compromise product integrity.
  • Calibration must be re-performed after corrective actions (recalibration, adjustment, or replacement) to ensure compliance.

Example Scenario:

  • During routine calibration: Sensor S2 reads 6.2°C, reference is 5.0°C → deviation +1.2°C (OOT, tolerance ±0.5°C).
  • Corrective Action: Sensor S2 replaced and system stabilized.
  • Post-correction calibration performed: Sensor now reads 5.1°C, reference 5.0°C → deviation +0.1°C → Pass.
  • Vehicle cleared for product transport only after OOT resolution documented.

Additional Considerations for Determining Calibration Frequency

  1. Risk Assessment:
    • Highly temperature-sensitive products (e.g., mRNA vaccines, biologics) may require more frequent calibration (every 6 months).
    • Low-risk products (e.g., CRT-stable items) may follow standard annual schedule.
  2. Manufacturer Recommendations:
    • Some sensor or controller manufacturers specify calibration intervals shorter than 12 months.
    • Example: PT100 sensors recommend recalibration every 6–9 months due to possible drift.
  3. Regulatory Expectations:
    • Inspections by FDA, MHRA, or EU GDP auditors expect evidence of calibration at regular intervals.
    • Missing calibration or lapses may result in observations, warning letters, or shipment holds.
  4. Operational Events:
    • Accidental exposure to extreme temperatures or mechanical shock may require unscheduled calibration.
    • Example: A trailer exposed to –5°C ambient overnight → sensors should be checked before resuming shipments.

Summary Table of Typical Calibration Frequency

Calibration EventFrequency / TriggerRationale / Notes
Routine CalibrationAnnuallyStandard GDP practice; ensures traceable accuracy
Initial QualificationBefore first useConfirms sensors/controllers are within tolerance prior to vehicle deployment
Post-Repair / ModificationAfter any changeEnsures system performance not affected by repairs, replacements, or upgrades
Out-of-Tolerance FindingsImmediately after correctionConfirms equipment is restored to compliance before next use
High-Risk Products / Critical SensorsSemi-annually or per risk assessmentAdditional assurance for sensitive pharmaceuticals

This detailed guidance ensures that all calibration activities are proactive, traceable, and compliant with GDP and regulatory expectations, preventing product excursions and regulatory non-compliance.

 

4. Calibration Process (Step-by-Step)

Step 1: Preparation

Objective:
Ensure all prerequisites, documentation, and equipment are ready before starting calibration activities.

Detailed Procedure:

  1. Review Calibration SOP and Equipment List
    • Review the current version of the Calibration Standard Operating Procedure (SOP) to understand the scope, frequency, methods, and acceptance criteria.
    • Verify that the list of instruments and sensors installed in the truck/trailer (such as temperature probes, digital display sensors, and data loggers) is up to date.
    • Example:
      • Truck ID: TT-002
      • Installed Sensors:
        • Sensor-1 (Return Air)
        • Sensor-2 (Supply Air)
        • Sensor-3 (Door Zone)
        • Controller Display Sensor
      • All will be included in the calibration activity.
  2. Identify All Sensors and Instruments Requiring Calibration
    • Prepare a calibration checklist identifying:
      • Sensor location
      • Sensor ID / Serial number
      • Manufacturer details
      • Last calibration date
      • Calibration due date
    • Example:
Sensor IDLocationManufacturerSerial No.Last Cal. DateDue Date
T001Return AirHoneywell12345601-Feb-202531-Jan-2026
T002Supply AirOmega78901201-Feb-202531-Jan-2026
  1. Verify Calibration Reference Standards
    • Ensure the reference standards (e.g., reference thermometers or simulators) used for calibration are traceable to national/international standards such as:
      • NIST (National Institute of Standards and Technology – USA)
      • NRC (National Research Council – Canada)
      • PTB (Physikalisch-Technische Bundesanstalt – Germany)
    • Confirm the reference instrument’s calibration certificate is valid and not expired.
    • Example:
      • Reference Thermometer Model: Fluke 1523
      • Calibration Certificate No.: FLK/2025/CT-011
      • Valid until: 15-Dec-2025

Step 2: Calibration Environment

Objective:
Ensure the calibration is conducted under stable, controlled conditions to minimize measurement error.

Detailed Procedure:

  1. Vehicle Placement
    • Park the truck/trailer in a shaded or covered area, away from direct sunlight, strong wind, or rain to prevent temperature fluctuations.
    • Avoid locations with ambient temperature changes greater than ±2°C during the calibration activity.
    • Example:
      • Perform calibration in a temperature-controlled garage (ambient 20 ±2°C).
  2. Temperature Control System
    • Ensure the truck/trailer’s refrigeration unit is turned off before calibration unless calibration is intended for the active system (i.e., verifying system function during operation).
    • If the calibration includes operational verification, set the unit to the intended temperature range (e.g., 2–8°C) and allow it to stabilize for at least 30–60 minutes before recording measurements.

Step 3: Calibration Execution

Objective:
Perform accurate calibration using certified reference standards and document all results.

Performed by:

  • An accredited external calibration laboratory (ISO/IEC 17025 certified)
    or
  • A qualified in-house technician trained in calibration procedures.

Detailed Procedure:

  1. Compare Readings with Reference Standards
    • Use a calibrated reference thermometer or temperature simulator to compare against each installed sensor.
    • Record both readings (display and reference) and calculate deviation.
    • Example:
      • Sensor Reading: +4.8°C
      • Reference Reading: +5.0°C
      • Deviation = –0.2°C (within ±0.5°C tolerance → PASS)
  2. Check at Multiple Temperature Points
    • Verify sensor accuracy at several key points across the operational range.
    • Example Temperature Points:
      • –20°C → for frozen transport validation
      • 0°C → for freezing point check
      • +5°C → for refrigerated range (2–8°C)
      • +25°C → for ambient storage (15–25°C)
    • Example Table:
Temperature PointReference Reading (°C)Sensor Reading (°C)DeviationPass/Fail
–20–20.1–19.8+0.3PASS
00.0+0.4+0.4PASS
+5+5.0+5.6+0.6FAIL (adjustment required)
+25+25.0+25.2+0.2PASS
  1. Document and Adjust
    • Record all results on the Calibration Data Sheet or Vehicle Calibration Record Form.
    • If the deviation is outside acceptable tolerance, adjust or recalibrate the sensor as per manufacturer’s instructions.
    • Post-adjustment, recheck accuracy to confirm compliance.

Step 4: Post-Calibration Verification

Objective:
Ensure calibration results are properly documented, traceable, and system functionality is restored.

Detailed Procedure:

  1. Affix Calibration Labels
    • Attach a calibration status label on each calibrated instrument, indicating:
      • Calibration Date
      • Next Due Date
      • Calibrated By
      • Equipment ID
    • Example Label:
  • Calibrated: 01-Feb-2025
  • Due: 31-Jan-2026
  • By: Q-Tech Labs
  • Equipment ID: T002
  1. Update Calibration Certificates and Logs
    • File the calibration certificates in the Equipment Calibration File.
    • Update the Master Calibration Log to reflect the completion date and next due date.
  2. Record All Results in the Vehicle Calibration Record
    • Maintain calibration data as per Good Documentation Practices (GDP) — entries must be legible, signed, and dated.
    • Example documentation includes:
      • Raw data sheets
      • Deviation reports
      • Certificates of calibration
      • Adjustments performed (if any)
  3. Confirm System Alarms and Displays Function Properly
    • After calibration, restart the refrigeration unit (if applicable) and confirm:
      • Temperature display is accurate
      • Alarm system activates at pre-set limits (e.g., <2°C or >8°C)
      • Data logger records data correctly
    • Example:
      • Simulate over-temperature by setting controller to 10°C.
      • Verify alarm activates and event is recorded by data logger.

Example Reference Standards and Tolerances

Instrument TypeTypical ToleranceCalibration FrequencyReference Standard
Temperature Sensor±0.5°C12 monthsNIST-traceable thermometer
Data Logger±0.5°C12 monthsTemperature simulator
Controller Display±1.0°C12 monthsReference thermometer

 

5. Acceptance Criteria

Calibration acceptance criteria define the maximum allowable deviation between the readings of vehicle-installed sensors/data loggers and the reference standards. Correctly defined criteria ensure that temperature-sensitive products are protected from excursions, while also being auditable and compliant with regulatory requirements.

5.1 Basis for Acceptance Criteria

  • Tolerance limits are derived from:
    • GDP Guidelines (EU, WHO, PIC/S)
    • ISO 17025 standards for calibration accuracy
    • Manufacturer specifications for sensors and data loggers
    • Product-specific stability requirements
  • The key principle: All readings must be within defined limits across the entire operational range of the vehicle.
  • Note: For highly sensitive products (e.g., mRNA vaccines), tolerances may be tightened further.

5.2 Typical Tolerance Limits

Storage TypeTemperature RangeTypical Calibration ToleranceRegulatory/Guidance BasisExample
Refrigerated2–8°C±0.5°CEU GDP Chapter 3.2.3, WHO TRS 957 Annex 5A refrigerated truck sensor reads 5.3°C when reference is 5.0°C → deviation = +0.3°C → Pass
Controlled Room Temperature (CRT)15–25°C±1.0°CISO 17025, FDA 21 CFR 211.68A CRT data logger reads 16.2°C when reference is 15.5°C → deviation = +0.7°C → Pass
Frozen≤ –20°C±1.5°CPIC/S PE 009-16, Health Canada GUI-0069A frozen storage probe reads –21.0°C when reference is –20.0°C → deviation = –1.0°C → Pass

5.3 Examples of Application

Example 1: Refrigerated Truck (2–8°C)

  • Sensor readings during calibration:
Sensor LocationReference Temp (°C)Sensor Reading (°C)Deviation (°C)Status
Front Zone5.05.3+0.3Pass
Rear Zone5.04.6–0.4Pass
Middle Zone5.05.8+0.8Fail

Interpretation: Middle zone sensor exceeds ±0.5°C → recalibration required before vehicle can be released for product transport.

Example 2: Controlled Room Temperature Vehicle (15–25°C)

  • During CRT calibration:
Sensor LocationReference Temp (°C)Sensor Reading (°C)Deviation (°C)Status
Front Compartment20.020.8+0.8Pass
Rear Compartment20.021.5+1.5Fail

Interpretation: Rear compartment sensor deviation exceeds ±1.0°C tolerance → adjustment needed.

Example 3: Frozen Vehicle (≤ –20°C)

  • Frozen transport validation:
Sensor LocationReference Temp (°C)Sensor Reading (°C)Deviation (°C)Status
Front Zone–20.0–21.0–1.0Pass
Rear Zone–20.0–18.2+1.8Fail

Interpretation: Rear zone sensor exceeds ±1.5°C → repair/replacement required. Critical for products like mRNA vaccines or monoclonal antibodies.

5.4 Factors Affecting Tolerance Limits

  1. Product Sensitivity
    • Highly temperature-sensitive products may require tighter tolerances.
    • Example: mRNA vaccines → ±0.3°C for refrigerated transport instead of ±0.5°C.
  2. Client SLA Agreements
    • Some clients specify stricter limits for monitoring and reporting.
    • Example: A contract requires data logger deviations ≤ ±0.2°C.
  3. Sensor Type and Location
    • Air vs. product temperature sensors may have different acceptable deviations.
    • Example: Probe directly in product load may have ±0.3°C; ambient air sensor ±0.5°C.

5.5 Regulatory and Audit Relevance

  • Regulators review calibration records and acceptance criteria during inspections.
  • Deviations outside defined tolerance without documented corrective action may result in:
    • Observation (EU GDP, WHO GDP)
    • Warning Letter (FDA, MHRA)
    • Product Hold or Recall if transport conditions cannot be verified

Audit Example:
During an EU GDP inspection, auditors check a refrigerated truck:

  • Sensor deviation: +0.8°C (tolerance ±0.5°C)
  • Finding: Vehicle released without recalibration → Non-compliance noted → Corrective action required.

5.6 Summary Table for Quick Reference

Transport TypeTemp RangeStandard ToleranceNotes / Example
Refrigerated2–8°C±0.5°CAll refrigerated vaccines; middle zone sensor > ±0.5°C → recalibrate
CRT15–25°C±1.0°CGeneral pharmaceutical storage; rear zone sensor > ±1.0°C → adjustment needed
Frozen≤ –20°C±1.5°CFrozen biologics; deviation beyond ±1.5°C → critical corrective action

6. Required Documentation

Proper documentation is a critical component of calibration activities. It ensures traceability, accountability, and compliance with regulatory requirements such as GDP, FDA, WHO, MHRA, EMA, and Health Canada. Well-maintained records provide evidence during audits, inspections, and internal quality reviews.

6.1.  Calibration SOP (Approved and Current)

Purpose:

  • Establishes the standardized procedure for calibration of all temperature monitoring, controlling, and recording devices.
  • Ensures uniformity across all vehicles and personnel performing calibration.

Details:

  • Must include: scope, responsibilities, calibration steps, acceptance criteria, and post-calibration activities.
  • Should be reviewed periodically and updated to reflect regulatory changes or process improvements.

Example:

  • SOP No.: GDP/ENG/002
  • Effective Date: 01-Jan-2025
  • Revision No.: 02
  • Approved by QA Head and Engineering Manager

Importance:

  • Auditors often check whether calibration was performed according to an approved procedure.

6.2.  List of Calibrated Instruments with ID and Due Date

Purpose:

  • Provides a master record of all sensors, data loggers, controllers, and reference instruments used in the fleet.
  • Helps track calibration schedules and due dates, preventing lapses in compliance.

Details:

  • Instrument ID / Serial Number
  • Location in vehicle (front, rear, middle, supply air, return air)
  • Manufacturer / Model
  • Last calibration date
  • Next due date

Example Table:

Instrument IDLocationManufacturerSerial No.Last CalibrationNext Due Date
T001FrontHoneywell12345601-Feb-202531-Jan-2026
T002RearOmega78901201-Feb-202531-Jan-2026
DL001CargoELPROLOG-04501-Feb-202531-Jan-2026

Importance:

  • Prevents assignment of uncalibrated vehicles for product transport.
  • Simplifies audit verification of calibration compliance.

6.3.  Calibration Certificates (Traceable to Standards)

Purpose:

  • Provides official evidence that each device has been calibrated against a recognized reference standard.
  • Ensures traceability to national/international standards (e.g., NIST, NRC, PTB).

Details:

  • Issued by ISO 17025-accredited laboratory or qualified in-house technician.
  • Must include:
    • Instrument ID and model
    • Reference equipment details
    • Calibration date
    • Tolerance limits
    • Measured deviations
    • Pass/Fail result

Example:

  • Certificate No.: NIST/2025/056
  • Instrument: Sensor T001
  • Reference: PT100-021
  • Result: Pass (±0.3°C deviation within ±0.5°C tolerance)
  • Validity: 12 months

Importance:

  • Regulatory inspectors (FDA, MHRA, EU GDP) require traceable certificates to ensure measurement accuracy and compliance.

6.4.  Calibration Status Labels

Purpose:

  • Provides visual confirmation that a device has been calibrated and is fit for use.
  • Helps operational personnel quickly identify calibrated and non-calibrated instruments.

Details:

  • Label should include:
    • Calibration date
    • Next due date
    • Technician initials or lab name
    • Status (Pass / Fail)

Example Label:

CALIBRATED

Date: 01-Feb-2025

Next Due: 31-Jan-2026

Tech: ABC Lab

Status: PASS

Instrument ID: T002

Importance:

  • Prevents use of out-of-calibration equipment, reducing risk of temperature excursions.

6.5.  Calibration Report

Purpose:

  • Consolidates all calibration activities, measurements, and outcomes into a formal record for review, traceability, and audits.

Contents of Calibration Report:

  1. Reference Equipment Details
    • Type, model, serial number, certificate number, and traceability.
    • Example: Fluke 1523 Reference Thermometer, Certificate FLK/2025/CT-011, Traceable to NIST.
  2. Calibration Points
    • Record readings at multiple points across the operational range.
    • Example: –20°C, 0°C, +5°C, +25°C depending on vehicle type.
  3. As-Found / As-Left Data
    • As-Found: Initial readings before adjustments.
    • As-Left: Final readings after calibration or adjustment.
  4. Acceptance Decision
    • Indicates whether the device passes tolerance limits and is ready for use.
    • Example: PASS / FAIL
  5. Technician Signature
    • Confirms that the calibration was performed by qualified personnel.
    • Includes date and contact info.

Importance:

  • Serves as the primary document for QA review before vehicles are cleared for GDP operations.

6.6.  Change Control or Deviation Reports (if Calibration Out-of-Tolerance)

Purpose:

  • Documents any issues when calibration results are out-of-tolerance (OOT) and the corrective/preventive actions (CAPA) taken.

Details:

  • Initiate a Deviation Report for OOT readings.
  • Conduct Impact Assessment for any product that may have been exposed to improper temperature.
  • Record corrective actions: sensor repair/replacement, recalibration, updated frequency.
  • Close the deviation only after QA review and approval.

Example:

  • OOT Deviation Report: DR-2025-021
  • Sensor S3 measured +6.1°C (tolerance ±0.5°C)
  • Action: Sensor replaced, recalibrated, vehicle requalified
  • QA Approval: 05-Mar-2025

Importance:

  • Ensures regulatory traceability of all non-conformances.
  • Prevents shipment of temperature-sensitive products under uncertain conditions.

Summary Table of Required Documentation

Document TypePurposeExample / Notes
Calibration SOPStandardized procedureSOP GDP/ENG/002
List of InstrumentsMaster list with IDs and due datesTable of sensors and data loggers
Calibration CertificatesTraceable proof of accuracyISO 17025 / NIST certificate
Calibration LabelsVisual confirmation of calibration statusCALIBRATED label with date, due date, tech
Calibration ReportFull record of readings, acceptance, and adjustmentsAs-found / As-left data table, acceptance decision, technician signature
Deviation ReportsDocument OOT occurrences and corrective actionsDR-2025-021 for sensor S3

7. Regulatory References

EU GDP Guidelines (2013/C 343/01)

  • Chapter 3.2.3: “Equipment used for monitoring of storage and transportation conditions should be calibrated at defined intervals.”
  • Annex 15 (Qualification & Validation): Calibration of critical instruments shall be traceable to national standards.

WHO GDP (TRS 957, Annex 5)

  • Section 5.3.2: “Temperature monitoring devices should be calibrated at regular intervals against a certified reference standard.”

Health Canada GUI-0069

  • Requires periodic calibration and validation of temperature-controlled transport equipment.

FDA 21 CFR Part 211.68 & 211.160(b)(4)

  • Instruments must be routinely calibrated, inspected, and checked for accuracy.

PIC/S PE 009-16 (Annex 15)

  • Calibration and maintenance records must be retained and traceable.

8. Related Qualification Activities

Calibration is a fundamental activity, but it is closely linked to vehicle qualification studies, which ensure that transport conditions consistently meet the required temperature specifications. Qualification demonstrates that vehicles can maintain product integrity during real-world operations:

8.1.  Temperature Mapping Study (Operational Qualification, OQ)

Purpose:

  • To verify the internal temperature distribution and sensor accuracy under controlled conditions before the vehicle is used for product transport.
  • Ensures that the vehicle’s temperature monitoring and control system can maintain uniform conditions across all zones.

Key Activities:

  1. Sensor Placement:
    • Install multiple sensors or data loggers at critical points inside the cargo area.
    • Typical zones: front, middle, rear, door area, top, bottom, supply air, return air.
  2. Temperature Profiling:
    • Operate the refrigeration or heating system to reach target temperatures (e.g., 2–8°C for refrigerated products).
    • Record temperature readings over a defined period to capture steady-state conditions.
  3. Data Analysis:
    • Compare sensor readings across all zones.
    • Identify any hot/cold spots or uneven distribution.
    • Evaluate the accuracy of installed sensors against calibrated reference instruments.

Example:

  • Vehicle: Refrigerated truck (2–8°C)
  • Front zone: 4.8°C
  • Middle zone: 5.2°C
  • Rear zone: 7.6°C
  • Reference thermometers show ±0.2°C accuracy.
  • Finding: Rear zone slightly warmer → calibration verified; airflow may be adjusted for uniformity.

Outcome:

  • Confirms that the installed sensors accurately monitor temperature.
  • Provides baseline data for operational and performance qualification.

8.2.  Performance Qualification (PQ) During Actual Transport Simulation

Purpose:

  • To validate the vehicle’s performance under real transport conditions, including variations in ambient temperature, loading/unloading operations, and door openings.
  • Ensures the system maintains target temperature throughout the entire transit cycle, not just in controlled static conditions.

Key Activities:

  1. Simulated Transport:
    • Load the truck with representative product or thermal load simulators (e.g., water-filled containers, thermal packs).
    • Include variations in load distribution to mimic real scenarios.
  2. Monitoring:
    • Use calibrated sensors and data loggers to record temperature throughout transit.
    • Record ambient conditions outside the vehicle.
  3. Evaluation:
    • Compare temperature readings against predefined acceptance criteria (e.g., 2–8°C ±0.5°C for refrigerated).
    • Confirm alarms and data logging function correctly during transit events such as door opening or route changes.

Example:

  • Vehicle: Frozen truck (–20°C)
  • Simulation: 6-hour transit with door opening at 2 hours
  • Data logger readings: –19.6°C to –20.4°C
  • Result: All readings within ±1.5°C → Pass PQ

Outcome:

  • Confirms vehicle performance under dynamic conditions.
  • Demonstrates compliance with GDP requirements for product safety during actual transport.

8.3.  Periodic Requalification

Purpose:

  • Ensures that the vehicle continues to meet operational and performance standards over time.
  • Addresses potential drift in sensors, system wear, or environmental changes that could affect temperature control.

Frequency:

  • Typically every 1–3 years, or as determined by risk assessment and regulatory requirements.
  • Also required after modifications, repairs, or replacement of sensors/controllers.

Key Activities:

  1. Repeat Calibration and Mapping:
    • Recalibrate all sensors and controllers.
    • Perform a temperature mapping study to verify OQ compliance.
  2. Performance Validation:
    • Conduct a PQ simulation if required by risk assessment.
    • Evaluate historical performance data from temperature logs.
  3. Document Review:
    • Update calibration certificates, validation reports, and vehicle qualification files.

Example:

  • Truck ID: TRK-007
  • Last PQ: 2022
  • Requalification 2025:
    • Sensor calibration verified
    • OQ mapping shows temperature deviation within ±0.4°C
    • PQ simulation confirms performance under real conditions
  • Result: Vehicle re-qualified and ready for GDP transport

Integration with Calibration

  • Calibration supports qualification: Accurate sensors and controllers are the foundation for OQ and PQ studies.
  • Qualification validates calibration: Mapping and PQ studies ensure that calibration results translate to reliable vehicle performance under operational conditions.
  • Regulatory Compliance:
    • EU GDP Annex 15 and WHO GDP TRS 957 require that calibration and qualification activities be documented and traceable.
    • Calibration certificates and qualification reports serve as evidence during audits.

Summary Table of Related Qualification Activities

ActivityPurposeKey StepsExample
Temperature Mapping (OQ)Verify uniform temperature distribution & sensor accuracySensor placement, temperature profiling, data analysisRear zone slightly warmer → airflow adjustment
Performance Qualification (PQ)Validate vehicle performance during actual transportSimulated load, dynamic monitoring, alarm verificationFrozen truck maintains –20°C ±0.4°C during 6-hour simulated route
Periodic RequalificationEnsure continued compliance over timeRecalibration, repeat OQ/PQ, documentation updateAnnual calibration + 3-year PQ requalification of refrigerated truck

9. Common Deficiencies in Audits

Auditors from regulatory agencies (FDA, MHRA, EMA, Health Canada, ANVISA, WHO) often inspect transportation operations to ensure that temperature-sensitive products are handled according to GDP requirements. Calibration-related deficiencies are frequent findings and can lead to observations, warning letters, or corrective action requirements. Understanding these deficiencies helps companies prevent compliance issues.

9.1.  Calibration Overdue or Missing for Temperature Sensors

Issue:

  • Vehicles are being used for product transport even though sensors, controllers, or data loggers have not been calibrated within the scheduled interval.

Regulatory Risk:

  • EU GDP Annex 15 / WHO TRS 957: Requires calibration at defined intervals.
  • FDA 21 CFR 211.68: Equipment must be routinely calibrated and inspected.

Example:

  • Truck TRK-005 has sensors with last calibration on 01-Jan-2024, due 31-Dec-2024.
  • The truck was used for shipping vaccines in Feb 2025 without recalibration.
  • Audit finding: Overdue calibration → Non-compliance.

Mitigation:

  • Maintain a Calibration Master List with due dates.
  • Set automated reminders in the QMS to schedule calibration before expiration.

9.2.  Certificates Not Traceable to National Standards

Issue:

  • Calibration certificates are available but cannot demonstrate traceability to recognized national or international standards (e.g., NIST, NRC, PTB).
  • Certificates issued by non-accredited or unqualified vendors may not meet GDP expectations.

Regulatory Risk:

  • ISO 17025 and GDP guidance require calibration to be traceable to certified reference standards.
  • Certificates lacking traceability are considered invalid for regulatory compliance.

Example:

  • Data logger calibration certificate shows “Calibration performed” but no reference to NIST or ISO 17025 accreditation.
  • MHRA inspector notes: “Calibration not traceable to national standards.”

Mitigation:

  • Use ISO 17025-accredited labs for calibration.
  • Verify and archive traceable certificates for each sensor and device.

9.3.  Data Loggers Used in Transport Not Verified or Calibrated

Issue:

  • Data loggers or integrated recording devices installed in trucks/trailers are assumed accurate without calibration verification.
  • This is common for rented or third-party vehicles.

Regulatory Risk:

  • WHO GDP Annex 5: Monitoring devices should be calibrated.
  • FDA 21 CFR Part 11: Data integrity requires validated measurement devices.

Example:

  • A rented refrigerated truck uses an onboard logger that has no calibration certificate.
  • Upon inspection, the auditor finds that recorded temperatures could not be verified.

Mitigation:

  • Always request calibration certificates from third-party vendors.
  • Include verification step in SOP before releasing vehicles for shipments.

9.4.  Incorrect Calibration Range (Not Covering Operational Limits)

Issue:

  • Sensors or controllers are calibrated only at one point or within a range narrower than the vehicle’s operational limits.
  • Critical for vehicles that transport multiple product types with different temperature ranges.

Regulatory Risk:

  • GDP requires calibration across the entire operational range to ensure accurate monitoring during excursions.

Example:

  • Refrigerated truck 2–8°C
  • Sensor calibrated only at 5°C → unknown accuracy at 2°C or 8°C.
  • Auditor finds calibration insufficient → observation issued.

Mitigation:

  • Calibrate sensors at multiple points:
    • For refrigerated: 2°C, 5°C, 8°C
    • For frozen: –20°C, –15°C, –10°C
    • For CRT: 15°C, 20°C, 25°C

9.5.  Missing Calibration Record for Replaced Sensors

Issue:

  • After sensor replacement, no new calibration record or certificate is available.
  • Sometimes old calibration certificates are incorrectly assumed valid.

Regulatory Risk:

  • GDP, ISO 17025, and FDA require each instrument to be individually calibrated before use.

Example:

  • Truck TRK-009 replaced rear zone sensor on 01-Mar-2025.
  • During audit, the new sensor had no calibration record.
  • Auditor observation: “Vehicle used without verified calibration → corrective action required.”

Mitigation:

  • Update Calibration Master List immediately after sensor replacement.
  • Perform calibration before vehicle is used for product transport.
  • Maintain records in QMS and vehicle files.

Summary Table of Common Deficiencies

DeficiencyDescriptionExampleRegulatory ReferenceMitigation
Overdue/Missing CalibrationSensors not calibrated on scheduleTruck used in Feb 2025; last calibration Dec 2024EU GDP Annex 15Maintain master list, schedule reminders
Certificates Not TraceableCalibration certificates lack NIST/PTB referenceLogger cert shows calibration done, no traceabilityISO 17025 / WHO GDPUse accredited labs, verify traceability
Unverified Data LoggersOnboard loggers not calibratedAuditor cannot verify recorded shipment temperatureWHO TRS 957, FDA 21 CFR 11Calibrate all loggers, keep certificates
Incorrect Calibration RangeSensors calibrated only at a single temperatureRefrigerated truck 2–8°C calibrated only at 5°CEU GDP, ISO 17025Calibrate at multiple operational points
Missing Record for Replaced SensorsNo certificate after sensor replacementRear sensor replaced, no calibration recordFDA 21 CFR 211.68Calibrate immediately, update records

 

10. Best Practices

  • Establish a calibration matrix for all GDP vehicles and devices.
  • Use ISO 17025-accredited labs for external calibration.
  • Integrate calibration schedules into Quality Management System (QMS).
  • Review calibration certificates during vendor qualification.
  • Implement preventive maintenance along with calibration.
  • Include calibration verification during transport validation.

Contact Us

Good Distribution Practice (GDP) Trainings

GxP Cellators Consultants offers comprehensive Good Distribution Practice (GDP) training programs aligned with global regulatory standards, including Health Canada, EU GMP, US FDA, TGA, MCC, and MHRA. These programs are available both on-site and remotely to meet client needs across the life sciences industry.

The training covers key GDP elements such as:

  • GDP principles and global regulatory expectations

  • Qualification of trailers and transport vessels

  • Temperature mapping requirements and study design

  • Establishing GDP Quality Management Systems (QMS)

  • Auditing and self-inspection practices

These sessions are designed to ensure safe, compliant, and efficient distribution of pharmaceutical products throughout the supply chain, focusing on practical, real-world applications of GDP requirements.

GxP Cellators Consultants are experts in GDP operations and provide full support for organizations seeking guidance, training, or compliance assistance in distribution activities as per international standards.

 


03/09/2025
Cleanroom-Trainings-1280x1707.webp

What are Cleanroom Trainings?

Cleanroom trainings are structured educational programs designed to equip personnel with the knowledge and skills necessary to work in controlled environments where contamination control is critical. These trainings cover principles of cleanroom design, operation, behavior, and regulatory compliance to ensure that staff consistently maintain product quality and patient safety.

 

Why are Cleanroom Trainings Required?

Cleanroom trainings are mandatory in pharmaceutical, biotechnology, medical device, and other regulated industries because:

  • Regulatory Compliance: Required by global agencies (FDA, EMA, Health Canada, WHO, etc.) for GMP compliance.
  • Contamination Control: To prevent microbial, particulate, and cross-contamination in manufacturing.
  • Personnel Safety: Ensures workers follow safe gowning and aseptic practices.
  • Operational Consistency: Promotes standardized behavior and practices inside classified environments.
  • Audit Readiness: Demonstrates documented evidence of employee competency during inspections.

Different Types of Cleanroom Trainings

Cleanroom training programs can be customized to meet the specific needs of facility operations, regulatory requirements, and employee roles. Common types include:

  1. Gowning and Degowning Procedures
    • Proper donning/doffing techniques for sterile and non-sterile environments.
    • Preventing contamination during entry/exit.
  2. Aseptic Technique Training
    • Handling sterile components, media fills, and interventions.
    • Correct use of isolators, RABS, and laminar airflow workbenches.
  3. Cleanroom Behavior and Discipline
    • Movement, communication, and material handling practices.
    • Prohibited activities and contamination risks.
  4. Cleanroom Operations & Environmental Monitoring
    • Sampling methods (air, surfaces, personnel).
    • Routine monitoring, trending, and deviation handling.
  5. Cleaning and Disinfection Training
    • Proper use of cleaning agents and disinfectants.
    • Rotation of disinfectants and sporicidal agents.
  6. HVAC and Airflow Awareness
    • Understanding unidirectional airflow, HEPA filters, pressure differentials.
    • Smoke study interpretation.
  7. Regulatory and GMP Compliance Training
    • FDA 21 CFR, EU-GMP Annex 1, Health Canada, WHO-GMP, ISO 14644 requirements.
    • Data integrity, documentation practices, and audit expectations.
  8. Specialized Training Modules
    • For vaccine manufacturing, gene therapy cleanrooms, or high-potent API facilities.
    • Role-based trainings (operators, QC, QA, maintenance, and engineering staff).

Cleanroom Gowning | Biologics Cleanroom Manufacturer

 

GxP Cellators Cleanroom Training Services

At GxP Cellators Consultants, we provide regulatory-compliant cleanroom training modules, designed and delivered by industry experts with decades of GMP experience.

✅ On-Site or Remote Training Options – tailored to your facility and operations.
✅ Customized Curriculum – aligned with your SOPs, processes, and risk assessments.
✅ Global Regulatory Alignment – trainings developed in accordance with:

  • US FDA (21 CFR Parts 210, 211, 600, 820)
  • Health Canada GMP
  • EU-GMP (Annex 1 & Annex 11)
  • MHRA (UK)
  • TGA (Australia)
  • ANVISA (Brazil)
  • WHO GMP
  • ISO 14644 & ISO 13485

Our goal is to establish a robust contamination control culture within your organization, ensuring compliance, efficiency, and readiness for inspections.

User Requirements Specification | Cleanrooms | Cleanroom URS


20/06/2025
Disinfectant-efficacy-studies-1280x691.webp

Disinfectant Efficacy Studies are critical to maintaining the sterility and cleanliness of cleanrooms in industries such as pharmaceuticals, biotechnology, medical devices, and healthcare. In these environments, contamination—whether microbial or particulate—can result in compromised product quality, patient safety issues, or regulatory non-compliance. Disinfectants are an essential tool for ensuring that these environments remain free from contamination, which is why efficacy studies are necessary to verify the effectiveness of disinfection processes.

Cleanroom Validations | Cleanroom | Cleanroom Qualifications

Let’s break down the key points on disinfectant efficacy studies, including why disinfectants are required, the types of disinfectants used, how efficacy is evaluated, and the regulatory guidelines for cleanroom disinfectant efficacy studies:

Why Disinfectants Are Required in Cleanrooms

1.     Microbial Control:

  • Cleanrooms are designed to maintain low levels of microbial contamination to prevent contamination of sensitive products (e.g., sterile pharmaceuticals, medical devices).
  • Disinfectants help control microorganisms such as bacteria, fungi, and viruses that may otherwise compromise product integrity or lead to product recalls.

2.     Compliance with Regulatory Standards:

  • Regulatory agencies such as the FDA, EMA, and Health Canada require manufacturers to implement effective cleaning and disinfection protocols to ensure that products meet safety and quality standards.

3.     Preventing Cross-Contamination:

  • Disinfectants help reduce the risk of cross-contamination between different batches or products, which is especially important in the production of sterile pharmaceuticals and medical devices.

4.     Maintaining Cleanroom Integrity:

  • Disinfectants are essential for maintaining air quality and surface cleanliness in cleanrooms, preventing particulate contamination and ensuring the controlled environment remains within set parameters for temperature, humidity, and cleanliness.

Cleanroom Documentation | Cleanroom Documentation Package

Different Types of Disinfectants Used in Cleanrooms

Various disinfectants are used in cleanrooms, each with distinct properties and applications. These disinfectants can be categorized based on their active ingredients:

1.     Alcohol-Based Disinfectants:

  • Ethanol (70%) and Isopropyl Alcohol (IPA) are the most commonly used disinfectants. They provide a quick, broad-spectrum antimicrobial action and are typically used for surface cleaning and sanitization.
  • Effective against bacteria, viruses, and fungi but can evaporate quickly, which may limit contact time.

2.     Chlorine-Based Disinfectants:

  • Sodium Hypochlorite (bleach) is effective against a wide range of pathogens. Still, its corrosive nature limits its use in cleanrooms, where it is typically used for occasional disinfection or in non-critical areas.

3.     Hydrogen Peroxide:

  • Hydrogen Peroxide (H₂O₂) is a strong disinfectant used for surface disinfection and fumigation.
  • Vaporized Hydrogen Peroxide (VHP) is commonly used for terminal cleaning or fogging in cleanrooms, effectively killing a broad range of microorganisms.

4.     Quaternary Ammonium Compounds (Quats):

  • Examples include Alkyl Dimethyl Benzyl Ammonium Chloride. These compounds have broad-spectrum antimicrobial activity but can leave a residue on surfaces, which may be undesirable in specific cleanroom environments.

5.     Peracetic Acid:

  • A potent disinfectant, Peracetic Acid is used for terminal disinfection and is effective against bacteria, spores, and fungi. It’s often used in combination with hydrogen peroxide.

6.     Formaldehyde:

  • Formaldehyde Gas is used for fumigation and terminal cleaning due to its high efficacy against a broad spectrum of pathogens, though it is highly toxic and requires strict handling protocols.

7.    Iodophors:

  • Povidone-Iodine is sometimes used in specific cleanroom environments where sterilization is required (e.g., healthcare settings), but it has limitations in its applicability in cleanrooms due to staining and residue.

How to Evaluate the Efficacy of Disinfectants

Disinfectant efficacy evaluation is essential to verify that the disinfectants are effective in eliminating or inactivating harmful microorganisms. The efficacy is typically evaluated through various standardized methods:

1.      Test Organism Selection:

  • Select microbial strains that represent the typical contaminants in cleanroom environments, such as:
    • Bacteria: Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli.
    • Fungi: Aspergillus niger, Candida albicans.
    • Viruses: Influenza, HIV, and Rotavirus.
    • Spores: Bacillus subtilis or Clostridium sporogenes.

2.     Surface Testing:

  • Surfaces (e.g., stainless steel, glass, laminate) are inoculated with the test microorganism, and after applying the disinfectant, the microbial reduction is measured.

3.     Suspension Testing:

  • A suspension of microbial organisms is mixed with the disinfectant, and the reduction of microorganisms is measured over time.

4.     Contact Time Evaluation:

  • The disinfectant’s effectiveness is tested at various contact times (e.g., 1, 5, 10, 15 minutes) to determine the minimal effective contact time required for the disinfectant to be effective.

5.     Bioburden Reduction:

  • Bioburden reduction (measured in log reductions) is calculated to assess the level of contamination before and after disinfection. A typical target is a 3- to 5-log reduction (99.9% to 99.999% kill).

6.     Residual Activity:

  • Test whether the disinfectant continues to provide antimicrobial action after application, especially when surfaces dry.

7.     Compatibility with Cleanroom Surfaces:

  • Evaluate whether the disinfectant leaves residues that could potentially compromise the cleanroom environment, such as particulates or toxic byproducts.

Vaccines Consultation | Vaccines I Vaccine Facility

 

 

Step-by-Step Guide for Disinfectant Efficacy Studies

1.     Objective and Standard Selection:

  • Define the purpose of the efficacy study (e.g., validating a new disinfectant, ensuring regulatory compliance).
  • Identify the standard you will be using for testing (e.g., ASTM, ISO, EN standards).

2.     Choose Microbial Strains:

  • Select appropriate test organisms that are representative of the common contaminants in cleanrooms.

3.     Prepare Test Surfaces:

  • Select cleanroom surfaces, such as stainless steel, vinyl, or glass, that mimic real-world conditions in the cleanroom.
  • Prepare the surfaces by inoculating them with microbial suspensions.

4.     Disinfectant Preparation:

  • Dilute the disinfectant to the appropriate concentration for testing and ensure it’s freshly prepared.

5.     Application and Contact Time:

  • Apply the disinfectant to the inoculated surfaces, maintaining the required contact time as specified by the manufacturer of the disinfectant.

6.     Sampling Post-Treatment:

  • After the designated contact time, collect samples (e.g., swabs or rinses) from the treated surfaces for microbiological analysis.

7.     Evaluate and Analyze Results:

  • Use microbial plating or quantitative PCR methods to assess the reduction in microbial load (log reduction).
  • Record the results and compare them to the required reduction criteria (typically a 3-log or 5-log reduction).

8.     Documentation:

  • Record all testing procedures, observations, and results in a formal report. This documentation should be stored for future inspections or regulatory audits.

Regulatory Guidelines and Requirements for Cleanroom Disinfectant Efficacy Studies

Several regulatory agencies provide guidelines that specifically address the efficacy of disinfectants in cleanroom environments:

1.      FDA (Food and Drug Administration):

  • The FDA’s Current Good Manufacturing Practices (cGMP) guidelines require the validation of cleaning and disinfection protocols. They focus on preventing contamination and ensuring that cleaning processes are effective in maintaining sterile environments (21 CFR Part 210 and 211).
  • FDA Guidance for Industry: Disinfectant testing must demonstrate the product’s ability to meet required microbial reduction levels.

2.     EMA (European Medicines Agency):

  • The GMP Guidelines from the EMA (EudraLex Volume 4) state that all cleaning procedures, including disinfection, must be validated and documented, with efficacy testing for microbial load reduction being a critical element of the process.

3.    Health Canada:

  • Health Canada follows Good Manufacturing Practice (GMP) guidelines, which include Environmental Control sections where disinfection efficacy is a key factor in ensuring sterile environments for pharmaceutical production (Health Canada’s Drug GMP Guidelines).

4.    TGA (Therapeutic Goods Administration):

  • TGA’s GMP Guidelines for pharmaceuticals also emphasize the requirement for effective cleaning and disinfection, with validation necessary to demonstrate the efficacy of the disinfection method (including the appropriate testing of disinfectant efficacy).

5.    MCC (Medicines Control Council):

  • The MCC, like other agencies, enforces GMP requirements that include validation of cleaning and disinfection procedures. Documentation of disinfectant efficacy is a part of maintaining compliance with South African pharmaceutical regulations.

6.    MHRA (Medicines and Healthcare products Regulatory Agency):

  • The MHRA guidelines (UK) specify that disinfection processes must be validated, and the efficacy of cleaning should be proven through documented testing. The MHRA GMP guidelines outline requirements for disinfection in cleanrooms, particularly regarding the validation of microbial control.

Contact Us

GxP Cellators Consultants provides technical and scientific consultation regarding your cleanroom operations. We offer comprehensive services related to Commissioning, Qualification, and Validation (CQV) for cleanrooms. Our services also include designing all required documentation for cleanroom operations, including cleanroom qualifications, operational Standard Operating Procedures (SOPs), and disinfectant efficacy studies.

Please feel free to contact us at for more information.


21/05/2025
Vaccines-Manufacturing.jpg

Vaccines are one of the most essential medical tools in preventing infectious diseases and maintaining public health. Your questions span fundamental understanding, manufacturing processes, facility setup, and global regulatory requirements. Here’s a detailed and structured response:

Advanced Therapy Medicinal Products I ATMPs I

 

1.  What Are Vaccines?

Vaccines are biological preparations designed to provide acquired immunity against specific infectious diseases. They work by stimulating the immune system to recognize and combat pathogens (such as viruses or bacteria), without causing the disease.

Types of Vaccines:

  • Live Attenuated Vaccines
    Contain weakened forms of the pathogen.
    Examples: MMR (Measles, Mumps, Rubella), BCG (Bacillus Calmette-Guérin for tuberculosis)
  • Inactivated Vaccines
    Contain pathogens that have been killed or inactivated.
    Examples: Polio (IPV), Hepatitis A
  • Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
    Use specific parts of the pathogen (like proteins or sugars).
    Examples: HPV, Hepatitis B
  • Toxoid Vaccines
    Use inactivated toxins produced by the pathogen.
    Examples: Tetanus, Diphtheria
  • mRNA-based Vaccines
    Use messenger RNA to instruct cells to produce a harmless piece of the pathogen, triggering an immune response.
    Example: Pfizer-BioNTech COVID-19 vaccine
  • Viral Vector Vaccines
    Use a harmless virus (not the pathogen itself) to deliver genetic material from the pathogen.
    Example: AstraZeneca COVID-19 vaccine

2.  Why Are Vaccines Required?

Vaccines are required for several critical public health reasons:

1.     Prevent Disease Outbreaks

Vaccines help stop the spread of contagious diseases by protecting individuals from infection. When a large portion of a population is vaccinated, it limits the opportunities for an outbreak.

2.    Reduce Mortality and Morbidity

Vaccines significantly lower the rates of illness (morbidity) and death (mortality) caused by infectious diseases such as measles, polio, and influenza.

3.    Establish Herd Immunity

Herd immunity occurs when enough people in a community are vaccinated, making it difficult for a disease to spread. This protects those who cannot be vaccinated, such as infants, adults, or people with certain medical conditions.

4.    Eradicate Diseases (e.g., Smallpox)

Widespread vaccination has successfully eradicated smallpox, bringing diseases like polio close to elimination. Continued vaccination efforts aim to wipe out more diseases globally.

5.    Reduce Healthcare Costs

Preventing disease through vaccination is far more cost-effective than treating illness. Vaccines reduce hospitalizations, medical treatments, and long-term care costs associated with preventable diseases.

In summary, vaccines protect public health, save lives, and minimize social and economic impact of infectious diseases.

3.  How Are Vaccines Manufactured?

General Steps in Vaccine Manufacturing

1.     Antigen Generation

  • The antigen is the active component that triggers an immune response.
  • It may be:
    1. Inactivated or attenuated pathogens (viruses or bacteria),
    2. Protein subunits,
    3. Or produced via recombinant DNA technology (e.g., in yeast, mammalian, or insect cells).

2.     Antigen Isolation and Purification

  • After generation, the antigen is separated and purified using:
    1. Filtration – removes impurities and debris.
    2. Centrifugation – separates components based on density.
    3. Chromatography – isolates the antigen based on chemical properties.

3.     Formulation

  • The purified antigen is mixed with:
    1. Adjuvants – to boost the immune response.
    2. Stabilizers – to maintain vaccine potency during storage.
    3. Preservatives – to prevent contamination (especially in multi-dose vials).

4.     Filling and Finishing

  • The formulated vaccine is filled into sterile containers such as vials or syringes using aseptic (sterile) techniques.
  • Containers are then sealed and inspected.

5.     Packaging and Labelling

  • Final products are packaged for distribution and labelled with critical information such as batch number, expiration date, and usage instructions.

6.     Quality Control and Batch Release

  • Each batch undergoes rigorous testing, including:
    1. Sterility tests – ensure no microbial contamination.
    2. Potency tests – confirm the vaccine’s effectiveness.
    3. Endotoxin tests – check for bacterial toxins.
    4. Identity tests – verify the correct antigen is present.
  • Only batches that meet all regulatory standards are released for use.

4.  GMP Manufacturing Facility Setup – Step-by-Step

GMP (Good Manufacturing Practices): These regulations and guidelines ensure that products are consistently produced and controlled according to quality standards. GMP compliance is critical in pharmaceuticals, biotechnology, medical devices, and food processing industries.

A.    Facility Requirements

1.     Site Selection

  • Location Considerations:
    • Situated in a clean, uncontaminated environment.
    • Away from potential sources of pollution (e.g., landfills, industrial zones).
    • Accessibility to utilities, skilled labor, and transport logistics.
  • Security & Compliance:
    • Secure perimeter fencing.
    • Surveillance systems and access control.
    • Compliance with local zoning and environmental regulations.

2.     Zoning and Layout

  • Classified Areas:
    • Designate clean zones (e.g., ISO Class 5–8 areas depending on process needs).
    • Proper segregation of:
      • Raw material storage
      • Production areas
      • Packaging areas
      • Quarantine and warehouse zones
  • Personnel and Material Flow:
    • Clearly defined paths to minimize cross-contamination.
    • Airlocks and pass-through boxes for material transfer.

3.     Modular Design

  • Flexibility:
    • Modular cleanroom panels and HVAC systems for future expansion or reconfiguration.
  • Contamination Control:
    • Seamless flooring, coved wall joints, and cleanroom-compatible materials.
    • HVAC systems with HEPA filtration to maintain pressure differentials and airflow directionality.

Cleanroom Panels | Biologics | Cleanroom Classifications

 

B.    Facility Areas (GMP Zones):

ZoneClassificationExample Activities
Grade AISO 5Aseptic filling
Grade BISO 7Background for Grade A
Grade CISO 8Solution prep
Grade DUnclassifiedEquipment wash

C.    Utilities:

1.     Clean Utilities (Direct Product Contact)

These utilities come into direct contact with the product or product contact surfaces and must meet strict purity standards:

  • Purified Water (PW) – Used for equipment cleaning, formulation, etc.
  • Water for Injection (WFI) – High-purity water used in parenteral product manufacturing.
  • Clean Steam – Generated from WFI or PW; used for sterilization processes.
  • Compressed Air (Oil-Free, Sterile) – Used in aseptic environments for equipment operation or product contact.
  • Gases (Nitrogen, CO₂) – Typically filtered and sterile; used for blanketing, purging, or processing.

2.     Dirty Utilities (Non-Contact Utilities)

These do not come into direct contact with the product but support facility and equipment operations:

  • Chilled Water – Used for HVAC cooling and process temperature control.
  • Steam (for HVAC) – Used for space heating or humidification.
  • Non-Potable Water – Used for non-contact cleaning or external equipment washdown.
  • Process Waste Drainage – Handles the disposal of process waste liquids.

3.     Environmental Controls

Maintain required cleanroom and process environment conditions:

  • HVAC with HEPA Filtration – Maintains cleanliness class by filtering particulates.
  • Differential Pressure Zones – Ensures directional airflow between rooms to prevent cross-contamination.
  • Temperature/Humidity Controls – Critical for product stability and environmental compliance.

5.  Regulatory Requirements for Vaccine GMP Facilities

Regulatory bodies ensure vaccines meet strict quality, safety, and efficacy standards. Here’s how each regulator oversees components of a vaccine manufacturing facility:

RegulatorJurisdictionKey GMP DocumentsFocus Areas
FDA (USA)USA21 CFR Part 210/211 & 600Facility design, batch release, sterility, BLA process
Health CanadaCanadaGUI-0001, C.01A.001Drug Establishment License, Site Reference Files
EMA (Europe)EUEudraLex Vol 4EU-GMP annexes (esp. Annex 1 – Sterile Products)
TGA (Australia)AustraliaPIC/S GMP GuideBased on EU GMP, requires TGA inspection and GMP certificate
WHO PQGlobal (for UN supply)WHO TRS 986 Annex 2Prequalification for global procurement, stringent reviews
SAHPRA/MCC (South Africa)South AfricaGMP Guidelines (based on WHO/EU)Facility licensing, batch certification

Key Regulatory Components Reviewed

1.     Premises and Cleanroom Classification

  1. Verification of facility layout and segregation
  2. Cleanroom classification per ISO 14644-1 / EU GMP Annex 1
  3. Surface/material compliance and hygienic design

GMP Facility | HVAC | Cleanrooms | GMP Trainings

2.     HVAC and Environmental Controls

  1. HEPA filtration performance and integrity testing
  2. Differential pressure maintenance between zones
  3. Monitoring and control of temperature, humidity, and air changes

3.     Validated Clean Utilities

  1. Qualification and routine monitoring of Purified Water (PW), Water for Injection (WFI), Clean Steam, Compressed Air, and gases
  2. Compliance with pharmacopeial standards (e.g., USP, EP)
  3. Periodic requalification and sampling protocols

4.     Manufacturing Processes and Batch Records

  1. Review of current Good Manufacturing Practice (cGMP)-compliant batch documentation
  2. Traceability, deviation handling, and reconciliation procedures
  3. Process flow verification against approved master batch records

Media Fill I Media Fill Consultants I Cleanrooms

5.     Aseptic Processing Validation

  1. Media fill trials (aseptic process simulation)
  2. Gowning qualification, aseptic technique assessments
  3. Sterility assurance level (SAL) evaluation

6.     Quality Management System (QMS)

  1. Documentation control, change control, and CAPA systems
  2. Internal audits, management reviews, and training records
  3. Risk management and deviation handling framework

7.     Qualified Equipment and Personnel

  1. Equipment IQ/OQ/PQ documentation
  2. Personnel training and qualification records
  3. Maintenance and calibration schedules

Analytical Instrument & System Qualification | Analytical Validation

8.     Microbial and Particulate Monitoring

  1. Environmental monitoring (EM) program for viable and non-viable particles
  2. Alert/action level trends and out-of-specification (OOS) handling
  3. Surface and personnel monitoring in aseptic areas

Cleanroom EMPQ | Cleanrooms | Cleaning Validation

9.     Cold Chain Management

  1. Temperature-controlled storage and transport validation
  2. Continuous temperature monitoring and alarm systems
  3. Procedures for excursions and impact assessment

6.   Additional Considerations

1.     Personnel Requirements

  • Trained & Gowning Compliant Staff:
    Ensure all personnel are adequately trained and compliant with gowning procedures to maintain contamination control.
  • Continuous Training & Certification:
    Implement ongoing training programs and certifications to update staff on protocols and regulatory requirements.

2.     Validation Requirements

  • Process Validation:
    Confirm that manufacturing processes consistently produce the desired product quality.
  • Cleaning Validation:
    Verify that cleaning procedures effectively remove residues and contaminants.
  • Environmental Monitoring Qualification:
    Assess and qualify the environmental monitoring systems to ensure cleanroom conditions are maintained.
  • Utility Qualification (IQ/OQ/PQ):
    Qualify utilities and equipment through Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).

3.     Documentation

  • Standard Operating Procedures (SOPs):
    Maintain detailed SOPs for all processes and activities.
  • Batch Manufacturing Records (BMR):
    Keep accurate and complete batch records for traceability and compliance.
  • Deviation Reports:
    Document and investigate any deviations from established procedures.
  • CAPA (Corrective and Preventive Actions):
    Implement and track corrective and preventive actions to address and prevent issues.

Cleanroom Documentation | Cleanroom Documentation Package

7.  Contact Us

Contact GxP Cellators Consultants for technical and scientific consultation regarding your vaccine manufacturing projects. Our expertise includes GMP facility design, qualifications, CQV (Commissioning, Qualification, and Validation), and designing the required quality systems.

Reach out to GxP Cellators at for more details.

 


04/05/2025
RABS_02-1280x778.webp

What Are RABS?

Restricted Access Barrier Systems (RABS) are advanced containment systems used in pharmaceutical and biotechnology manufacturing environments. They are designed to provide a physical and aerodynamic barrier between the operator and the critical cleanroom environment, particularly aseptic processing zones. RABS limit contamination risks by reducing direct human intervention and maintaining environmental control.

Why Are RABS Being Used?

Restricted Access Barrier Systems (RABS) are being increasingly implemented in pharmaceutical manufacturing environments due to their ability to bridge the gap between traditional cleanroom operations and complete isolator systems. Key reasons for their adoption include:

  • Enhanced Contamination Control
    RABS provides a robust physical and aerodynamic barrier between operators and critical zones, significantly reducing microbial and particulate contamination risk during aseptic processing.
  • Regulatory Compliance
    RABS help manufacturers meet the stringent requirements of international regulatory bodies such as the FDA and EMA and align with cGMP and EU Annex 1 standards, particularly for sterile product manufacturing.
  • Improved Operator Safety
    By minimizing direct contact with open product zones and hazardous substances, RABS enhance occupational safety, especially when handling potent or toxic compounds.
  • Cost-Effective and Flexible
    Compared to isolators, RABS are generally more cost-effective and less complex to retrofit into existing facilities. They offer flexibility for various production scales and are quicker to implement without major structural modifications.

Advanced Therapy Medicinal Products I ATMPs I

 

Types of RABS

1.     Open RABS (oRABS):

Open Restricted Access Barrier Systems (oRABS) are designed to provide a physical barrier between the operator and the critical aseptic zone while maintaining open airflow with the surrounding cleanroom. Key characteristics include:

  • Shared Air Environment
    The system draws air from the surrounding cleanroom (typically Grade B), which is filtered through terminal HEPA filters within the RABS unit.
  • Non-Sealed Design
    While physical barriers such as rigid panels, glove ports, and doors are in place, the system is not airtight. This allows for easier access but requires strict environmental controls.
  • Environmental Requirement
    Due to the system’s open nature, oRABS must be operated within a Grade B cleanroom to maintain the required aseptic conditions in the critical zone (Grade A under RABS).
  • Operator Interventions
    Designed to limit—rather than eliminate—operator interventions, oRABS rely on stringent aseptic techniques and validated procedures.

2.     Closed RABS (cRABS):

Closed Restricted Access Barrier Systems (cRABS) are fully enclosed systems designed to maximize contamination control and minimize operator exposure to critical environments. These systems are more advanced than open RABS and offer enhanced sterility assurance.

  • Fully Enclosed Configuration
    The cRABS maintains a sealed barrier around the aseptic zone, with all operations conducted through glove ports or automation. This enclosure significantly reduces the risk of contamination from human interaction.
  • Integrated HEPA Filtration
    Air supplied to the internal environment is filtered through high-efficiency particulate air (HEPA) filters. The filtered air is recirculated within the enclosure or exhausted depending on the application.
  • Positive Pressure Maintenance
    The internal chamber operates under positive pressure relative to the surrounding environment to prevent ingress of contaminated air in case of minor leaks.
  • Higher Sterility Assurance Level (SAL)
    Combining physical containment with strict airflow control, cRABS offer a higher product protection level than open systems and are suitable for critical aseptic manufacturing processes.

3.     Hybrid RABS:

Hybrid RABS combine key features of both isolators and traditional RABS, offering enhanced contamination control with greater operational flexibility. These systems are often selected when a higher level of sterility assurance is required but full isolator implementation is not feasible.

  • Integrated Design Approach
    Hybrid RABS incorporate structural and operational elements from isolators (e.g., partial enclosure, limited access) while maintaining the ergonomic and cost advantages of RABS.
  • Decontamination Capability
    Some hybrid RABS are designed to support automated decontamination processes, such as hydrogen peroxide (H₂O₂) vapor bio decontamination, to reduce bioburden before aseptic processing begins.
  • Partial Sealing
    While they offer improved containment over open RABS, hybrid systems are not fully sealed like isolators. Controlled access and validated airflows remain critical.
  • Use Cases
    Ideal for operations requiring improved environmental control over open RABS but without the full infrastructure investment needed for isolators

Biosafety Cabinets

 

Qualification of RABS

Qualification Strategy includes DQ, IQ, OQ, and PQ phases, ensuring that the RABS is designed, installed, and functions as intended.

1.     Design Qualification (DQ)

  • Verifies that the design meets user requirements and regulatory expectations.
  • Design review, risk assessments, and documentation of specifications.

2.     Installation Qualification (IQ)

  • Confirms that the RABS system and components are installed correctly.
  • Checks utility connections, component specs, drawings, software versions, etc.

3.     Operational Qualification (OQ)

  • Verifies that the RABS operates within predetermined parameters.
  • Tests include:
    • HEPA filter integrity testing (e.g., DOP/PAO testing)
    • Airflow visualization (smoke studies)
    • Alarm verification
    • Gasket and door seal integrity
    • Pressure decay tests

4.     Performance Qualification (PQ)

  • Demonstrates that the RABS performs effectively in routine operation.
  • Tests include:
    • Environmental monitoring (viable and non-viable particles)
    • Aseptic process simulation (media fill)
    • Operator interventions testing

Overall Qualification Strategy

PhaseFocusKey Activities
DQDesignReview URS, vendor designs, risk assessment
IQInstallationComponent verification, wiring, software validation
OQFunctionAirflow, filter integrity, smoke study, alarms
PQPerformanceMedia fill, EM, process simulation

All qualification phases must be documented and traceable, complying with GxP and Annex 1 requirements.

Pros and Cons of Using RABS

Pros

  • High sterility assurance level
  • Cost-effective vs isolators
  • Lower human intervention
  • Easily retrofitted in existing cleanrooms
  • Flexible operations

Cons

  • Requires controlled cleanroom environment (Grade B or higher)
  • Human intervention still possible (vs isolators)
  • Glove port risks (integrity, ergonomic strain)
  • More maintenance than isolators (especially for open RABS)

Contacting GxP Cellators Consultants

GxP Cellators is a reputed service provider specializing in GxP-compliant validation, qualification, and consulting. We can assist in:

  • Full RABS qualification (DQ to PQ)
  • Risk assessments
  • URS generation and review
  • Smoke studies and airflow visualization
  • Protocol preparation and execution

You can reach out to us through:

  • Website: www.gxpcellators.com
  • Email:
  • Phone: +1-306-715-9460

Cleanroom Documentation | Cleanroom Documentation Package


27/04/2025
GDP_Trailer-1280x853.webp

What is GDP for pharmaceutical distribution?

Good Distribution Practices (GDP) are international guidelines to ensure that medicines are consistently stored, transported, and handled under suitable conditions to ensure quality, safety, and efficacy.

  • GDP focuses not only on warehouses and wholesalers but also heavily on transportation (trailers, shipping vessels, etc.).
  • Transportation must preserve integrity, prevent contamination, maintain controlled conditions (especially temperature-sensitive products), and protect against theft or counterfeiting.

Good Distribution Practices (GDP) Certification

 

General Requirements for Trailers and Shipping Vessels (GDP-compliant Transport)

To qualify shipping trailers and vessels under GDP:

Temperature Control:

  • Capability to maintain required conditions (e.g., 2–8°C for refrigerated, 15–25°C for room temperature).

Calibration and Qualification:

  • Temperature mapping (thermal qualification).
  • Equipment calibration (temperature sensors, humidity sensors, data loggers).

Monitoring:

  • Real-time temperature monitoring with alarms.
  • GPS tracking often required for security and monitoring.

Cleaning & Maintenance:

  • Documented cleaning procedures to avoid contamination.

Security Measures:

  • Tamper-proof systems, sealed trailers, secure loading/unloading procedures.

Change Management and CAPA:

  • Process for corrective actions and preventive actions if issues are found.

Documentation:

  • Transport records, calibration certificates, deviation records, maintenance logs.

Training:

  • Drivers and operators must be trained in GDP and handling requirements.

How to Qualify Shipping Trailers and Vessels for GDP Compliance

Typical steps for qualification:

  • User Requirement Specification (URS): Define what you need (temperature range, payload, security).
  • Design Qualification (DQ): Document that the design meets requirements.
  • Installation Qualification (IQ): Verify installation — equipment matches specification.
  • Operational Qualification (OQ): Test the operational capabilities (like temperature control).
  • Performance Qualification (PQ): Test the trailer/vessel under simulated real-world conditions.
  • Thermal Mapping:
    • Map temperature distribution during empty and loaded conditions.
  • Calibration:
    • Certify all measurement equipment (sensors, loggers).
  • Validation Report:
    • A final summary stating the trailer/vessel is fit for pharmaceutical distribution.

GMP Auditing Services I GMP Audits I GMP Auditors I

 

Regulatory Requirements & Guidelines

Region/AgencyKey GDP Guidance/Requirement
Health CanadaFollows GUI-0069 – Guidelines for Temperature Control of Drug Products during Storage and Transportation
USFDANo separate GDP guideline. Relies on CGMPs (21 CFR parts 210 and 211), especially storage and distribution sections.
EMA/EU-GMPEU GDP Guidelines (2013/C 343/01), very detailed transport and temperature requirements.
WHOWHO Good Distribution Practices for pharmaceutical products TRS 957, Annex 5
ANVISA (Brazil)RDC No. 430/2020 on Good Distribution Practices
TGA (Australia)TGA follows PIC/S GDP Guide for transport and distribution.
MCC (South Africa)Medicines Control Council GDP guidelines follow WHO model closely.

Certification Bodies for Trailers and Vessels

Here’s the nuance: Regulators (Health Canada, FDA, EMA, etc.) do not directly “certify” trailers or vessels.
Instead:

  • Third-party certification bodies provide GDP certification audits for distribution companies, warehouses, and transport equipment.
  • Certification can cover specific trailers/vessels as part of a distribution network’s compliance.

References and Regulations

Special Notes

  • In Canada, Health Canada inspectors will inspect GDP compliance during licensing inspections (Drug Establishment Licenses).
  • In the US, FDA inspects GDP indirectly via CGMP inspections.
  • In EU, national agencies (like MHRA UK, BfArM Germany) inspect GDP compliance directly during licensing or GxP inspections.

Typical Certifications Achievable

✅ GDP Compliance Certificate (for the transport fleet)
✅ ISO 9001 (Quality Management System) – optional but very helpful
✅ ISO 13485 (for medical devices transport) – optional depending on goods
✅ TAPA Certification (for security in transport)

Need GDP Certification for Your Trailers and Shipping Vessels?

If you are planning to obtain Good Distribution Practices (GDP) certification for your trailers, trucks, or shipping vessels, GxP Cellators Consultants is here to help.

We specialize in:

  • Implementing GDP-compliant quality systems,
  • Performing full qualification of transport assets (trailers, reefers, containers, vessels),
  • Conducting temperature mapping, calibration validation, and
  • Preparing comprehensive documentation to support your licensing applications to regulatory agencies such as Health Canada, USFDA, EMA, TGA, and WHO.
  • Ensure your transport fleet meets regulatory requirements before inspection.
  • Avoid costly delays in your licensing process.
  • Work with experienced GxP compliance experts.

Contact GxP Cellators Consultants at to get your trailers and shipping vessels fully qualified and GDP-ready!

 


25/04/2025
Fill-Finish-1280x853.webp

What is Media Fill?

A Media Fill, also known as a Process Simulation, is a critical microbiological validation technique used in aseptic manufacturing. This test replaces the actual pharmaceutical product with a sterile nutrient-rich growth medium (commonly Tryptic Soy Broth) to simulate the entire aseptic production process.

The purpose is to assess whether the manufacturing operations, including equipment, environment, and personnel practices, can consistently prevent microbial contamination. It is a fundamental requirement to ensure the sterility of parenteral drug products and to meet international regulatory standards.

Vaccines | Vaccine Facility Qualifications | Vaccine Cleanrooms

 

Why is Media Fill Required?

Media Fills are essential for:

  • Demonstrating the sterility assurance of aseptic processing
  • Confirming that procedures, personnel, equipment, and environment consistently prevent contamination
  • Meeting global regulatory requirements for sterile pharmaceutical products

Media Fill Process Overview

Using a microbial growth medium, a Media Fill (Process Simulation) replicates your routine aseptic manufacturing operations. Below is a step-by-step outline:

1.     Preparation & Planning

  • Define the scope: product lines, fill volumes, and critical interventions to simulate.
  • Select and qualify a growth medium (e.g., Tryptic Soy Broth) that supports a broad spectrum of microorganisms.
  • Establish pass/fail criteria (typically zero positives per batch).

2.     Environmental & Equipment Setup

  • Ensure all equipment (sterile filling lines, isolators, lyophilizers) is cleaned, sterilized, and qualified.
  • Verify cleanroom classification (Grade A in B background) and complete airborne particle/environmental monitoring.

3.     Operator Gowning & Training

  • Operators do gowning per SOPs for aseptic operations.
  • Each intervention (e.g., needle change, line stop) is pre-planned and rehearsed.

4.     Simulated Aseptic Filling

  • Replace the drug product with sterile medium.
  • Run a full production batch, including all routine and off-normal interventions.
  • Document each step in real time: start/end times, deviations, and operator actions.

5.     Incubation & Inspection

  • Incubate filled units at the specified temperature (e.g., 20–25 °C for 7 days, then 30–35 °C for 7 days).
  • Examine visually for turbidity or pellet formation indicating microbial growth.

6.     Data Analysis & Reporting

  • Record the number of contaminated units.
  • Compare against acceptance criteria (e.g., 0 positives per 100 units).
  • Investigate any failures, perform root-cause analysis, and implement corrective actions.

7.     Requalification & Trending

  • Schedule media fills at least semi-annually or after significant process/facility changes.
  • Trend results over time to demonstrate ongoing process control.

Terminal Sterilization and Aseptic Sterilization

 

Prime Components of Media Fills

Successful execution of a Media Fill depends on integrating critical components that mirror real-world aseptic manufacturing. These include:

  • Trained Aseptic Operators

    Personnel must be fully qualified in aseptic techniques, gowning procedures, and routine/intervention handling within cleanroom environments.

  • Controlled Cleanroom Environment (Grade A/B)

    To ensure contamination control, media fills must be conducted under strict environmental conditions—typically Grade A laminar airflow within a Grade B background.

  • Validated Equipment and Materials

    All production equipment, transfer tools, and single-use systems must be cleaned, sterilized, and validated for aseptic compatibility.

  • Simulated Interventions

    Routine and non-routine activities—such as needle changes, line stoppages, and equipment adjustments—must be incorporated to mimic actual manufacturing conditions.

  • Sterile Media (e.g., Tryptic Soy Broth – TSB)

    To simulate product filling, a broad-spectrum microbial growth medium must be used. The medium must be sterile, clear, and free of growth inhibitors.

  • Incubation and Inspection Protocols

    Filled units are incubated under validated conditions (typically 14 days) and visually inspected for turbidity or microbial growth, indicating a breach in aseptic integrity.

Regulatory Requirements for Media Fills

Media Fill testing (aseptic process simulation) is mandatory for sterile pharmaceutical manufacturing and strictly regulated by global health authorities. These tests are essential to demonstrating the reliability of aseptic operations and maintaining regulatory compliance.

Key Regulatory Guidelines:

Standard Regulatory Expectations:

  • Routine Execution:

    Media Fills must be performed at least twice yearly (semi-annually) for each aseptic process line.

  • Re-Validation Triggers:

    Requalification is required after:

    • Equipment upgrades or replacements
    • Process changes or procedural updates
    • Facility renovations or layout modifications
    • Significant deviations or contamination events
  • Acceptance Criteria:

    Zero contamination is expected in most cases. The number of units filled and accepted depends on batch size and risk-based assessment.

Need Support?

GxP Cellators Consultants offer expert guidance on designing, executing, and interpreting Media Fills in line with global regulatory expectations.

📧 Contact:
Let our team help ensure your aseptic processes meet compliance standards and inspection-readiness.


23/04/2025
ATMP22042025.webp

Advanced Therapy Medicinal Products (ATMPs) are an emerging class of medicines based on genes, cells, or tissues that offer revolutionary treatment options, especially for diseases that are currently untreatable or poorly managed with conventional pharmaceuticals.

What are ATMPs?

Advanced Therapy Medicinal Products (ATMPs) are innovative biopharmaceuticals that utilize genes, cells, or engineered tissues to treat, prevent, or potentially cure a wide range of serious diseases. These therapies are particularly promising for conditions such as genetic disorders, cancers, autoimmune diseases, and tissue/organ damage, where conventional pharmaceuticals often fall short.

Types of ATMPs:

1.     Gene Therapy Medicinal Products (GTMPs):

  1. Deliver functional genes to replace faulty ones or to provide new functions.
  2. Example: Zolgensma (for spinal muscular atrophy).

Revolution in Cell and Gene Therapy | Cell Therapy | Cleanrooms

2.     Somatic Cell Therapy Medicinal Products (sCTMPs):

  1. Use cells manipulated outside the body and reintroduced to repair or modify tissue function.
  2. Example: Provenge (for prostate cancer).

3.     Tissue-Engineered Products (TEPs):

  1. Use engineered cells or scaffolds to repair, regenerate, or replace damaged tissues.
  2. Example: Holoclar (for corneal repair using limbal stem cells).

4.     Combined ATMPs:

  1. Include one above integrated with a medical device (e.g., scaffolds, matrices).
  2. Example: A tissue-engineered cartilage product with a biodegradable implant.

 

Significance of ATMPs over Traditional Pharmaceuticals

 

FeatureTraditional DrugsATMPs
MechanismChemical or biological activityCell, gene, or tissue-based therapeutic action
TargetOften symptom-basedOften root cause or regenerative
CustomizationStandardized (mass-produced)Often patient-specific (e.g., autologous therapies)
Therapeutic ScopeChronic disease managementCurative potential in many cases
ExamplesStatins, antibiotics, insulinCAR-T cells, CRISPR-based gene editing, stem cell therapies

Challenges with ATMPs and GMP (Good Manufacturing Practice)

Advanced Therapy Medicinal Products (ATMPs) development and production present unique challenges beyond conventional pharmaceutical manufacturing. Due to their biological nature and high degree of customization, maintaining compliance with Good Manufacturing Practice (GMP) standards is significantly more complex.

1.      Product Complexity

  • Biological Instability: ATMPs involve living cells, viral vectors, or inherently fragile genetic constructs and are prone to degradation.
  • Variability: Biological raw materials and processes introduce high variability, making achieving batch-to-batch consistency difficult.

2.     Manufacturing Challenges

  • Personalization: Many ATMPs are autologous, requiring manufacturing steps tailored to each individual patient.
  • Scale and Infrastructure: Production is often small-scale, and requires specialized cleanrooms, closed systems, and aseptic processing to maintain sterility and viability.

3.     Supply Chain Issues

  • Limited Shelf Life: Most ATMPs have short shelf life, sometimes just hours or days, demanding real-time coordination.
  • Cold Chain Logistics: Strict temperature controls are needed throughout the supply chain to preserve product integrity.
  • Just-in-Time Delivery: Manufacturing, testing, and delivery must be highly synchronized with clinical administration windows.

4.     Quality Control (QC)

  • Limited Material for Testing: ATMPs are often produced in small batches with minimal excess material for quality testing.
  • Complex In-Process Testing: Real-time monitoring of biological activity, identity, purity, and potency is essential and technically demanding.

5.     GMP Compliance Challenges

  • Rigid Frameworks vs. Flexible Needs: Traditional GMP standards may not accommodate the dynamic nature of ATMP development, especially for individualized therapies.
  • Hospital-Based Manufacturing: Integrating GMP principles in hospital or academic settings (for autologous or early-phase therapies) poses logistical and regulatory hurdles.
  • Evolving Standards: Regulatory expectations and GMP guidelines for ATMPs still evolve and may vary across regions.

Cell and Gene Therapies I CMC | CMC Safety

 

Regulatory Approach on ATMPs

1.      EMA (European Medicines Agency) – EU

  • Regulation: ATMPs in the European Union are governed by Regulation (EC) No 1394/2007, specifically designed to ensure the safety and efficacy of gene therapy, somatic cell therapy, and tissue-engineered products.
  • Specialized Committee: The Committee for Advanced Therapies (CAT) evaluates the scientific aspects of ATMPs, ensuring they meet stringent standards for approval.
  • Centralized Marketing Authorization: Centralized approval through the EMA is required for marketing ATMPs across all EU member states.
  • Hospital Exemption (Article 3): Allows certain non-routine, personalized treatments (e.g., autologous therapies) to be exempt from centralized approval, provided they are produced and used within a single hospital or medical institution.

2.     FDA (U.S. Food and Drug Administration) – USA

  • Regulation Body: ATMPs in the U.S. fall under the Center for Biologics Evaluation and Research (CBER) at the FDA, which oversees biologics, including gene therapy and cell therapy products.
  • Regulatory Framework:
    • IND (Investigational New Drug): Required for clinical trials involving ATMPs to assess safety and efficacy before approval.
    • BLA (Biologics License Application): Needed for the commercial approval of ATMPs.
    • Expedited Pathways:
      • RMAT (Regenerative Medicine Advanced Therapy): Provides priority review and more flexible clinical trial designs for promising regenerative therapies.
      • Breakthrough Therapy Designation: Expedited development and review processes for therapies addressing serious or life-threatening conditions.

3.     TGA (Therapeutic Goods Administration) – Australia

  • Regulation: In Australia, ATMPs are regulated under the Biologicals Framework which governs gene therapies, cell therapies, and tissue-engineered products.
  • Risk-Based Classification: ATMPs are classified into four risk classes (Class 1 to 4) based on their complexity, patient risk, and potential for harm.
  • Focus on Patient Safety: Emphasis on autologous therapies, ensuring that the safety of personalized treatments (derived from patient’s own cells) is thoroughly assessed.

4.     MSS (Malaysia’s National Pharmaceutical Regulatory Agency) – Malaysia

  • Regulation: ATMPs are regulated by the Cell and Gene Therapy Products (CGTPs) Guidelines issued by the National Pharmaceutical Regulatory Agency (NPRA).
  • Guideline Focus: These guidelines ensure that cells and gene therapies are handled under strict quality control, emphasizing traceability from collection through processing and administration.
  • Compliance with GMP: ATMPs must comply with GMP and additional regulations specific to cell handling, genetic modifications, and patient safety.

5.     WHO (World Health Organization) – Global

  • Technical Guidance: The WHO provides guidance on regulating cell-based therapies and genetic medicines globally, to ensure safe and ethical practices in developing and using ATMPs.
  • Global Harmonization: The WHO fosters international regulatory harmonization, facilitating easier global access to ATMPs while maintaining safety and efficacy standards.
  • Focus on Low-Income Regions: WHO’s efforts also focus on making advanced therapies accessible and affordable in resource-constrained settings, while ensuring that safety and quality are not compromised.

6.     ANVISA (Agência Nacional de Vigilância Sanitária) – Brazil

  • Regulation: In Brazil, ATMPs are categorized as Advanced Cell Therapy Products (ACTPs), subject to regulatory frameworks set by ANVISA, the Brazilian Health Regulatory Agency.
  • Regulatory Pathway: ANVISA has developed a dedicated regulatory pathway for expedited review, ensuring that promising treatments can be brought to market more quickly in Brazil.
  • Clinical Trial and Approval Process: The approval process includes assessing clinical trial data, safety profiles, and post-market surveillance to ensure the ongoing safety of ATMPs in the population.

Contact Us

For technical, scientific, and GMP consulting services related to your ATMP (Advanced Therapy Medicinal Products) products, please get in touch with GxP Cellators Consultants at .


18/04/2025
GCP_QMS-1280x853.webp

A Good Clinical Practice Quality Management System (GCP QMS) is a structured framework that ensures sponsor companies maintain compliance with global regulatory standards throughout a clinical trial’s lifecycle. Regulatory bodies such as the FDA (U.S. Food and Drug Administration), ICH (International Council for Harmonisation), and EMA (European Medicines Agency) emphasize the critical role of a robust QMS in safeguarding subject safety, data integrity, and ethical conduct in clinical research.

Technical Writers | Quality Management System | Technical Writing

 

GCP QMS Requirements for Sponsor Companies

Sponsor companies bear the ultimate responsibility for the initiation, management, and financing of clinical trials. Their QMS must be capable of:

  • Ensuring compliance with ICH E6(R3), FDA 21 CFR Parts 312, 50, 54, and EMA guidelines
  • Managing risk and quality across the clinical development spectrum
  • Overseeing vendors, CROs, and clinical sites effectively
  • Documenting decisions and corrective actions throughout trial conduct

What is Quality Assurance in Pharma & Why Is It Important?

 

QMS Structure / Segments as per FDA, ICH & EMA

A well-structured GCP QMS should address the following core segments, aligning with ICH E6(R3), FDA Guidance for Industry – Q10, and EMA’s Reflection Papers:

1.     Governance & Oversight

  • Quality policy
  • Organizational structure
  • Management responsibilities and review processes

2.     Quality Risk Management

  • Risk identification and evaluation
  • Mitigation strategies
  • Risk-based monitoring (RBM)

3.     Document & Record Control

  • SOPs, policies, and manuals
  • Trial Master File (TMF) and audit trails
  • Version control and archival practices

4.     Training & Qualification

  • GCP training programs
  • Role-specific competency tracking
  • Vendor/CRO qualification

5.     Vendor Oversight

  • Qualification, selection, and management of CROs and third-party vendors
  • Performance monitoring
  • Contractual and regulatory compliance

6.     Audits & Inspections

  • Internal and external audits
  • CAPA (Corrective and Preventive Actions) system
  • Readiness for regulatory inspections

7.     CAPA & Continuous Improvement

  • Root cause analysis
  • Implementation and effectiveness verification
  • Lessons learned processes

8.     Deviation & Issue Management

  • Deviation reporting and analysis
  • Protocol deviation tracking
  • Escalation and resolution pathways

9.     Data Integrity & Systems Validation

  • Electronic system validation (CSV)
  • ALCOA+ principles
  • eSource and eTMF standards

10. Trial Oversight & Reporting

  • Oversight plans
  • DSURs, CSR submissions
  • Real-time metrics dashboards

Prime Components for Designing a Sponsor GCP QMS

To design a compliant and efficient GCP QMS for sponsors, focus on:

  • ICH E6(R3) implementation strategy
  • Cross-functional SOP integration
  • Vendor and CRO quality assurance plans
  • Digital quality management tools (eQMS)
  • Inspection readiness culture
  • Documentation lifecycle management

Why GxP Cellators Consultants?

GxP Cellators Consultants specializes in developing, implementing, and optimizing GCP QMS frameworks for sponsor companies of all sizes. With deep regulatory knowledge and hands-on experience, we tailor solutions that align with FDA, EMA, and ICH expectations.

Contact us today at:
Your partner in GxP compliance, clinical quality, and inspection readiness.

Bioanalytical GLP Consultants | GLP Consultants | OECD GLP


17/04/2025
WFI_16042025-1-1280x853.webp

Clean and Dirty Utilities in Biologics Projects

Clean Utilities

These utilities come into direct or indirect contact with the product, manufacturing environment, or packaging and must meet strict GMP (Good Manufacturing Practice) and GxP requirements.

Examples:

  • Purified Water (PW)
  • Water for Injection (WFI)
  • Clean Steam
  • Process Gases (Nitrogen, Compressed Air, CO₂, O₂ – when in contact with product)
  • HVAC for classified cleanroom environments

Purified Water | Water for Injections | Purified Water Systems

 

 

Commissioning of HVAC Systems

 

Dirty Utilities

These do not contact the product and are primarily used for support functions. They don’t require the same stringent GMP controls but must still be reliable.

Examples:

  • Chilled Water
  • Steam (Plant Steam)
  • Industrial Gases
  • Non-GMP HVAC
  • Waste Management Systems
  • Compressed Air (non-GMP)

Qualification Requirements: Clean vs. Dirty Utilities

Utility TypeQualification RequirementRegulatory Focus
Clean UtilitiesFull GMP qualification (IQ/OQ/PQ), Critical utility validation, Periodic requalificationFDA, EMA, WHO, etc.
Dirty UtilitiesEngineering qualification, Functional testing, Maintenance validationGEP (Good Engineering Practices)
Water for Injections I Clean Utilities I WFI I Purified Water I

 

Step-by-Step Utility Qualification Process

For Clean Utilities

1.     Design Qualification (DQ)

  • Ensure system design meets URS (User Requirements Specification)
  • Review P&IDs, specifications, and materials of construction
  • Document: DQ Report

2.     Installation Qualification (IQ)

  • Verify equipment/system is installed per design
  • Review calibration certificates, component tags, wiring, etc.
  • Document: IQ Protocol & Report

3.     Operational Qualification (OQ)

  • Test system operations against functional specs
  • Include alarm testing, control ranges, safety features
  • Document: OQ Protocol & Report

4.     Performance Qualification (PQ)

  • Test system under load conditions (e.g., actual production)
  • Monitor microbial/chemical parameters (e.g., for PW/WFI)
  • Document: PQ Protocol & Report

5.     Validation Summary Report

  • Summarize DQ-IQ-OQ-PQ
  • Justify operational acceptance
  • Document: VSR

6.     Periodic Review & Requalification

  • SOP-driven requalification
  • Trending & deviation reviews

For Dirty Utilities

1.     Engineering Design Review

  • Ensure GEP compliance
  • Evaluate efficiency, safety, capacity
  • Document: Engineering Design Assessment

2.     Installation & Functionality Check

  • Check installation as per design
  • Confirm operational capability
  • Document: System Verification Report

3.     Performance Tests (where required)

  • System pressure, flow, alarms
  • Calibration of key instruments
  • Document: Functionality/Performance Test Report

4.     Handover to Maintenance

  • Ensure preventive maintenance plan is in place
  • Document: Handover Certificate

Documentation Package

  • URS (User Requirements Specification)
  • FS/DS (Functional/Design Specification)
  • P&IDs, GA Drawings
  • Risk Assessment (FMEA)
  • DQ/IQ/OQ/PQ Protocols & Reports
  • Calibration & Maintenance Logs
  • Validation Master Plan (VMP)
  • SOPs (System Use, Sampling, Cleaning, Maintenance)
  • Traceability Matrix

GxP Cellators Consultants’ Expertise

GxP Cellators Consultants is a highly experienced team specializing in utility qualification for biologics manufacturing facilities, including greenfield and brownfield projects.

Services and Strengths:

1.     Clean & Dirty Utility Qualification

  • Turnkey qualification for PW, WFI, clean steam, gases
  • Engineering qualification in chilled water, plant steam, HVAC, and more

2.     Qualification Documentation Design

  • Custom protocol development (DQ, IQ, OQ, PQ)
  • Risk-based qualification approach aligned with ISPE & FDA guidelines

3.     On-Site Execution Support

  • Expert-led testing and validation
  • Deviation management, change control, CAPA documentation

4.     Site Utilities and HVAC Systems

  • Full commissioning and qualification of HVAC (cleanroom grades A-D)
  • Airflow visualization (smoke studies), recovery rate, pressure cascade validation

5.     GMP Readiness Programs

  • End-to-end support for GMP inspections
  • Readiness gap assessments and remediation plans
  • Regulatory audit support and technical documentation review

Commissioning Qualification and Validation I CQV Services I GxP


Our Presence



Saskatchewan, Canada

Calgary, Canada

Toronto, Canada

North Carolina, USA

Frankfurt, Germany


Indiana, USA

Get in Touch



+1 (306) 715 -9460


Saskatchewan, Canada

https://www.gxpcellators.com


You cannot copy content of this page

Verified by MonsterInsights